| Symbol | MAP2K5 |
|---|
| Full Name | Mitogen-Activated Protein Kinase Kinase 5 |
|---|
| Alias | MEK5 |
|---|
| Chromosome | 15q23 |
|---|
| NCBI Gene ID | 5608 |
|---|
| UniProt ID | Q13131 |
|---|
| Ensembl ID | ENSG00000108691 |
|---|
| Protein Family | MAP kinase kinase (MEK) family |
|---|
MAP2K5 (also known as MEK5) encodes mitogen-activated protein kinase kinase 5, a dual-specificity protein kinase that serves as the specific upstream activator of ERK5 (also known as Big MAP Kinase 1, BMK1). The MAP2K5-ERK5 signaling axis represents a distinct MAPK cascade that plays critical roles in neuronal development, synaptic plasticity, cell survival, and stress responses. Unlike other MAP kinase pathways, the MEK5-ERK5 pathway has unique functions in the nervous system that are particularly relevant to neurodegenerative disease pathogenesis and neuroprotection.
The MEK5 protein consists of 471 amino acids and contains a kinase domain with characteristic motifs required for dual-specificity phosphorylation. MEK5 is distinguished from other MAP2K family members (MEK1/2, MEK3/6, MEK4/7) by its highly specific substrate specificity for ERK5, as it does not efficiently phosphorylate other MAPKs. This specificity makes MEK5 a critical regulator of ERK5-mediated signaling in neurons and glia.
The MAP2K5-ERK5 pathway constitutes one of five major MAPK cascades in mammalian cells:
flowchart TD
A["Growth Factors<br/>Stress Signals"] --> B["MEKK2/3"]
B --> C["MAP2K5 MEK5"]
C --> D["ERK5 BMK1"]
D --> E["MEF2<br/>CREB<br/>c-Fos"]
D --> F["Epithelial<br/>Differentiation"]
D --> G["Neuronal<br/>Survival"]
D --> H["Synaptic<br/>Plasticity"]
D --> I["Mitochondrial<br/>Function"]
MAP2K5 is activated by MAPKKK proteins, primarily MEKK2 (MAP3K2) and MEKK3 (MAP3K3), which respond to various extracellular signals:
- Growth factors: BDNF, NGF, EGF
- Cellular stress: Oxidative stress, endoplasmic reticulum stress
- Synaptic activity: Glutamate receptor activation
- Inflammatory signals: Cytokine signaling in glia
Activated ERK5 phosphorylates multiple transcription factors and effectors:
- MEF2 family: Myocyte enhancer factor 2 (MEF2A-D)
- CREB: cAMP response element-binding protein
- c-Fos: Immediate early gene product
- SGK: Serum- and glucocorticoid-induced kinase
- BIM: Pro-apoptotic Bcl-2 family protein
MAP2K5-ERK5 signaling is essential for multiple aspects of brain development:
Axon Growth and Guidance:
- Regulates axonal extension and branching
- Controls growth cone dynamics
- Mediates guidance cue responses
- Essential for proper circuit formation
Neuronal Differentiation:
- Promotes neuronal fate specification
- Controls dendritic arborization
- Regulates synapse formation
- Essential for cortical development
The MEK5-ERK5 pathway plays critical roles in learning and memory:
Long-Term Potentiation (LTP):
- Required for LTP induction in hippocampal neurons
- Controls AMPA receptor trafficking
- Regulates spine morphogenesis
- Mediates activity-dependent gene expression
Memory Formation:
- ERK5 activation in hippocampus during memory tasks
- CREB phosphorylation and gene transcription
- Consolidation of synaptic changes
- Long-term memory stability
MEK5-ERK5 signaling mediates neuroprotective responses:
Oxidative Stress Response:
- Activation of antioxidant gene expression
- Protection against ROS-induced cell death
- Maintenance of mitochondrial function
- Upregulation of survival proteins
BDNF-Mediated Survival:
- ERK5 is downstream of TrkB receptor
- Mediates BDNF's neuroprotective effects
- Promotes neuronal survival in injury models
- Essential for trophic factor signaling
Anti-apoptotic Signaling:
- Phosphorylation and inhibition of pro-apoptotic BIM
- Activation of MEF2-dependent survival genes
- Cross-talk with PI3K/Akt pathway
- Regulation of caspase activity
ERK5 regulates mitochondrial biology in neurons:
- Controls mitochondrial biogenesis
- Regulates mitochondrial dynamics (fusion/fission)
- Maintains mitochondrial membrane potential
- Protects against mitochondrial apoptosis
The MEK5-ERK5 pathway is implicated in multiple aspects of AD pathogenesis:
Amyloid-Beta Effects:
- Aβ induces ERK5 activation in neurons
- Paradoxically, ERK5 activation can be both protective and detrimental
- MEK5-ERK5 signaling in microglial activation
- Regulation of inflammatory responses
Tau Pathology:
- ERK5 can phosphorylate tau at multiple sites
- GSK-3β and ERK5 collaboration in tau hyperphosphorylation
- Role in tau aggregation and spread
- Therapeutic targeting considerations
Synaptic Dysfunction:
- ERK5 is required for synaptic plasticity deficits in AD models
- Memory consolidation impairments
- dendritic spine loss mechanisms
Therapeutic Potential:
- MEK5 inhibitors as AD therapeutic strategy
- Targeting ERK5 activation to reduce neuroinflammation
- Modulating tau pathology through ERK5
MAP2K5-ERK5 signaling is relevant to PD pathophysiology:
Dopaminergic Neuron Survival:
- ERK5 activation protects dopaminergic neurons
- Neuroprotective effects against oxidative stress
- Response to mitochondrial toxins (MPTP, 6-OHDA)
- Role in L-DOPA-induced dyskinesia
α-Synuclein Pathology:
- ERK5 activation in response to α-synuclein aggregation
- Potential role in protein clearance pathways
- Involvement in cellular stress responses
Therapeutic Targeting:
- MEK5-ERK5 modulators for PD treatment
- Neuroprotection strategies
Recent research has identified MEK5-ERK5 in ALS:
Motor Neuron Survival:
- MEK5 is protective in SOD1 models
- ERK5 activation promotes survival
- Cross-talk with other survival pathways
Therapeutic Potential:
- Targeting MEK5 as ALS therapeutic strategy
Huntington's Disease:
- ERK5 dysregulation in HD models
- Role in mutant huntingtin toxicity
- Therapeutic targeting potential
Stroke and Brain Injury:
- ERK5 activation in ischemic preconditioning
- Neuroprotection in stroke models
- Recovery and plasticity mechanisms
MAP2K5 is widely expressed in the brain:
- High expression: Hippocampus (CA1-3, dentate gyrus), cerebral cortex, cerebellum
- Cellular localization: Neurons (soma, dendrites, synapses), some glial cells
- Developmental regulation: Higher expression during development
- Activity-dependent: Synaptic activity modulates expression
- Neurons: Primary expression in excitatory and inhibitory neurons
- Astrocytes: Lower expression, upregulated in injury
- Microglia: Inducible expression in activated states
- Oligodendrocytes: Present in myelin-producing cells
MAP2K5 genetic variants have been associated with:
- Psychiatric disorders: Depression, antidepressant response
- Neurological conditions: Stroke susceptibility
- Cancer: Some somatic mutations in tumors
- Development: Rare developmental disorders
- Pharmacogenomics of MEK inhibitors
- Predictors of treatment response
- Potential biomarker applications
The specificity of MEK5 for ERK5 makes it an attractive target:
Small Molecule Inhibitors:
- BIX02188: Selective MEK5 inhibitor
- BIX02189: MEK5 inhibitor
- Compound 43: ERK5 inhibitor
Therapeutic Applications:
- Neurodegeneration prevention
- Cancer therapy (brain penetrant versions)
- Inflammatory conditions
- Blood-brain barrier penetration
- Optimal timing of intervention
- Pathway compensation mechanisms
- Cell type-specific roles: How does MEK5 function differ across neuronal populations?
- Temporal dynamics: What are the precise timing requirements for ERK5 signaling?
- Crosstalk mechanisms: How does MEK5-ERK5 interact with other pathways?
- Therapeutic window: What is the optimal modulation strategy?
- Single-cell studies: Cell-type specific ERK5 functions
- Optogenetics: Light-controlled ERK5 activation
- Biomarkers: ERK5 activity as disease biomarker
- Combination therapy: MEK5 modulation with other targets
¶ Protein Structure and Function
The MEK5 protein contains several key structural features essential for its function:
Kinase Domain:
- Dual-specificity protein kinase domain (residues 50-300)
- ATP-binding site in the active site cleft
- Phosphorylation sites for activation (S218, T222)
- DFG motif for substrate recognition
Regulatory Regions:
- N-terminal docking domain for ERK5 interaction
- C-terminal region for protein-protein interactions
- Nuclear localization signals
- Nuclear export signals
Isoform Variants:
- MEK5α: Full-length isoform (471 aa)
- MEK5β: Truncated isoform lacking N-terminal region
- Different tissue distribution and function
MEK5 phosphorylates ERK5 through a canonical kinase mechanism:
- Activation loop phosphorylation: S218 and T222 autophosphorylation
- ERK5 binding: D-domain mediated recruitment
- Catalysis: phosphate transfer from ATP to ERK5 Y218
- Release: ERK5 dissociation for downstream signaling
MEK5 interacts with multiple proteins to execute its functions:
- MEKK2/3: Upstream MAPKKK activators
- ERK5: Primary substrate
- ERK5 nuclear carriers: Chaperones for nuclear import
- Phosphatases: MKP5, MKP7 for pathway termination
- Scaffold proteins: KSR for pathway optimization
MAP2K5 knockout mice have provided insights into its functions:
MEK5 Knockout:
- Embryonic lethality around E9.5-10.5
- Defects in heart development
- Impaired neuronal development
- Vascular abnormalities
Conditional Knockouts:
- Neuron-specific deletion: Learning and memory deficits
- Glia-specific deletion: Altered inflammatory responses
- Muscle-specific deletion: Metabolic phenotypes
Transgenic and knock-in models have been developed:
ERK5 Transgenic:
- Neuronal ERK5 overexpression: Enhanced LTP
- Constitutive ERK5: Developmental abnormalities
- Dominant-negative ERK5: Impaired memory
Disease Models:
- AD models with MEK5 modulation: Altered pathology
- PD models with MEK5 manipulation: Changed outcomes
- Stroke models: Ischemic preconditioning effects
MEK5-ERK5 signaling in behavior:
Learning and Memory:
- MEK5/ERK5 knockouts: Impaired spatial memory
- Constitutive activation: Enhanced memory
- Specific brain region manipulation: Distinct effects
Motor Function:
- Cerebellar MEK5: Motor coordination
- Basal ganglia: Habit formation
- Motor neuron ERK5: Function in ALS models
Emotional Behavior:
- Depression-related behaviors
- Anxiety-like behaviors
- Response to stress
MEK5-ERK5 interacts with other MAPK cascades:
ERK1/2 Pathway:
- Parallel activation by growth factors
- Shared downstream targets (CREB)
- Distinct temporal patterns
- Different cellular outcomes
JNK Pathway:
- Often opposing functions
- Stress-activated vs growth factor activated
- Cell fate decisions: survival vs death
- Coordination in development
p38 Pathway:
- Similar stress-activated pattern
- Common substrates
- Complementary functions
MEK5-ERK5 integrates with multiple pathways:
cAMP/PKA:
- Cross-activation of CREB
- Shared target genes
- Modulation by cAMP
PI3K/Akt:
- Co-activation by growth factors
- Parallel survival signaling
- Intersection at BAD phosphorylation
Calcium Signaling:
- Activity-dependent activation
- Calmodulin interactions
- Activity-dependent transcription
MEK5-ERK5 has distinct spatial pools:
Nuclear ERK5:
- Transcriptional regulation
- Gene expression programs
- Long-term effects
Cytoplasmic ERK5:
- Cytoskeletal effects
- Immediate responses
- Local signaling
Synaptic ERK5:
- Synaptic plasticity
- Local translation
- Spine function
ERK5 activity as a biomarker:
Diagnostic:
- Disease state identification
- Subtype classification
- Progression monitoring
Prognostic:
- Outcome prediction
- Treatment response
- Survival markers
Therapeutic Monitoring:
- Target engagement
- Pathway modulation
- Efficacy measures
MEK5-ERK5 pathway targeting strategies:
Direct MEK5 Modulators:
- Agonists for neuroprotection
- Antagonists for specific contexts
- Isoform-specific compounds
ERK5-Targeted Compounds:
- Direct ERK5 inhibitors
- Allosteric modulators
- Substrate competitors
Combination Approaches:
- With other neuroprotective agents
- With anti-inflammatory drugs
- With disease-modifying therapies
Current status of MEK5-ERK5 targeted therapies:
- Preclinical validation ongoing
- CNS-penetrant compounds in development
- Biomarker development for patient selection
- Combination trial designs in planning
Substrate Specificity:
- High specificity for ERK5
- Km for ERK5: ~0.5 μM
- Vmax: ~100 pmol/min/mg
Regulation:
- Autophosphorylation on activation loop
- Feedback phosphorylation by ERK5
- Phosphatase-mediated deactivation
Phosphorylation:
- S218 and T222: Activation loop phosphorylation
- Multiple serine/threonine sites for regulation
Other Modifications:
- Acetylation: Affects kinase activity
- Ubiquitination: Protein turnover
- Sumoylation: Localization changes
MEK5 is found in various complexes:
Signaling Complexes:
- MEKK2/3-MEK5-ERK5 modules
- Scaffold protein complexes (KSR)
- Nuclear import complexes
Functional Complexes:
- Transcription factor complexes
- Mitochondrial complexes
- Synaptic complexes
MAP2K5 is evolutionarily conserved:
- Mammals: Highly conserved (95%+ identity)
- Birds: ~85% identity
- Fish: ~70% identity
- Drosophila: Homolog DSOR1
- C. elegans: Homolog mek-2
The MEK5-ERK5 pathway is functionally conserved across species:
- Developmental functions
- Stress responses
- Synaptic plasticity
MEK5-ERK5 in oxidative stress:
Direct Effects:
- ROS activates MEKK2/3
- MEK5-ERK5 activation
- Antioxidant gene expression
Indirect Effects:
- Mitochondrial protection
- DNA damage repair
- Protein homeostasis
The pathway in ER stress:
- IRE1-MEKK2-MEK5-ERK5 axis
- Unfolded protein response
- Cell survival signaling
ERK5 in mitochondrial health:
- Biogenesis regulation
- Dynamics control
- Quality control pathways
- Apoptosis regulation
Activators:
- Brain-penetrant MEK5 agonists
- Upstream receptor agonists
- Exercise mimetics
Inhibitors:
- Selective MEK5 inhibitors
- ERK5 inhibitors
- Combination approaches
Lifestyle Interventions:
- Exercise enhances ERK5
- Dietary factors
- Stress management
Experimental Approaches:
- Gene therapy
- Cell-based therapy
- Optogenetic stimulation
- Understanding cell-type specificity
- Developing better biomarkers
- Creating brain-penetrant compounds
- Defining optimal intervention timing
- Neuroprotection in AD/PD
- Stroke prevention
- ALS treatment
- Traumatic brain injury
MEK5 interacts with multiple kinases:
Upstream Kinases:
- MEKK2 (MAP3K2): Primary activator
- MEKK3 (MAP3K3): Alternative activator
- TAK1 (MAP3K7): Stress-activated
Other MAP2Ks:
- Potential cross-talk with MEK1/2
- Shared upstream regulators
- Parallel pathway interaction
Transcription Factors:
- MEF2 family: Primary ERK5 targets
- CREB: Phosphorylation target
- c-Fos: Induction target
Scaffolding Proteins:
- KSR: Scaffold for MAPK cascade
- JIP proteins: Alternative scaffolds
- MP1: Endosomal scaffolding
Regulatory Proteins:
- Phosphatases: MKP5, MKP7
- Ubiquitin ligases: Degradation control
- Chaperones: Protein folding
MEK5-ERK5 in disease onset:
Early Events:
- Subtle synaptic changes
- Early mitochondrial dysfunction
- Initial transcriptional changes
Progression Factors:
- Sustained pathway dysregulation
- Inflammatory response activation
- Protein aggregation interaction
Neuronal vulnerability factors:
Intrinsic Factors:
- High metabolic demand
- Limited regenerative capacity
- Excitable state sensitivity
Extrinsic Factors:
Evidence supporting MEK5 as target:
- Pathway activation in disease models
- Neuroprotective effects of pathway activation
- Correlation with disease severity
Chemistry Challenges:
- Achieving brain penetration
- Maintaining selectivity
- Balancing agonist vs antagonist effects
Biological Challenges:
- Complex temporal requirements
- Cell-type specificity needs
- Pathway compensation issues
Rationale for combinations:
- MEK5 + other neuroprotective pathways
- MEK5 + anti-inflammatory approaches
- MEK5 + disease-modifying agents
¶ Models and Systems
Cell culture systems for studying MEK5:
Primary Neurons:
- Hippocampal neurons: Synaptic plasticity studies
- Cortical neurons: Development studies
- Dopaminergic neurons: PD models
Cell Lines:
- PC12 cells: Differentiation studies
- SH-SY5Y: Neurodegeneration models
- N2A cells: Molecular mechanisms
Animal models for MEK5-ERK5:
Mouse Models:
- Conditional knockouts
- Transgenic overexpression
- Disease model crosses
Zebrafish Models:
- Developmental studies
- CNS visualization
- Drug screening
Human models:
- Brain organoids: Development
- Disease-specific iPSCs
- Microfluidic devices
¶ Measurement and Detection
Measuring MEK5-ERK5 activity:
Kinase Assays:
- In vitro kinase assays
- Immunoprecipitation kinase assays
- Fluorescence-based detection
Detection Methods:
- Phospho-ERK5 antibodies
- Activity-based probes
- Reporter constructs
Measuring expression:
mRNA:
- qRT-PCR
- RNAseq
- In situ hybridization
Protein:
- Western blot
- Immunohistochemistry
- ELISA
MEK5 (MAP2K5) shows moderate expression in:
- Cerebral cortex - Layer 5 pyramidal neurons
- Hippocampus - CA1 and CA3 regions
- Cerebellum - Purkinje cells
- Olfactory bulb - Mitral cells
| Region |
Expression Level |
Data Source |
| Cerebral cortex |
Medium |
Mouse Brain Atlas |
| Hippocampus |
Medium |
Mouse Brain Atlas |
| Cerebellum |
Low-Medium |
Human MTG |
Single-cell RNA sequencing shows MAP2K5 expression in:
- Pyramidal neurons
- Purkinje cells
- Some interneurons